Related references
Note: Only part of the references are listed.Death from high-risk prostate cancer versus cardiovascular mortality with hormonal therapy A Decision Analysis
Nataniel H. Lester-Coll et al.
CANCER (2013)
Current standards and future directions for prostate cancer radiation therapy
Michael Pinkawa et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2013)
International Variation in Prostate Cancer Incidence and Mortality Rates
Melissa M. Center et al.
EUROPEAN UROLOGY (2012)
Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapy
Steven Eric Finkelstein et al.
IMMUNOTHERAPY (2012)
COMBINATION OF EXTERNAL BEAM RADIOTHERAPY (EBRT) WITH INTRATUMORAL INJECTION OF DENDRITIC CELLS AS NEO-ADJUVANT TREATMENT OF HIGH-RISK SOFT TISSUE SARCOMA PATIENTS
Steven E. Finkelstein et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Incidence of Secondary Cancer Development After High-Dose Intensity-Modulated Radiotherapy and Image-Guided Brachytherapy for the Treatment of Localized Prostate Cancer
Michael J. Zelefsky et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Phase II Study of Long-Term Androgen Suppression With Bevacizumab and Intensity-Modulated Radiation Therapy (IMRT) in High-Risk Prostate Cancer
Jacqueline Vuky et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
LONG-TERM FOLLOW-UP OF A PROSPECTIVE TRIAL OF TRIMODALITY THERAPY OF WEEKLY PACLITAXEL, RADIATION, AND ANDROGEN DEPRIVATION IN HIGH-RISK PROSTATE CANCER WITH OR WITHOUT PRIOR PROSTATECTOMY
Arif Hussain et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
Michel Bolla et al.
LANCET (2012)
Clinicalopportunitiesincombiningimmunotherapywithradiationtherapy
Steven E. Finkelstein et al.
FRONTIERS IN ONCOLOGY (2012)
Permanent Interstitial Low-Dose-Rate Brachytherapy for Patients with Localised Prostate Cancer: A Systematic Review of Randomised and Nonrandomised Controlled Clinical Trials
Frank Peinemann et al.
EUROPEAN UROLOGY (2011)
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease
Axel Heidenreich et al.
EUROPEAN UROLOGY (2011)
PET and PET/CT in radiation treatment planning for prostate cancer
Michael Pinkawa et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
QUALITY OF LIFE AFTER WHOLE PELVIC VERSUS PROSTATE-ONLY EXTERNAL BEAM RADIOTHERAPY FOR PROSTATE CANCER: A MATCHED-PAIR COMPARISON
Michael Pinkawa et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
PELVIC NODAL RADIOTHERAPY IN PATIENTS WITH UNFAVORABLE INTERMEDIATE AND HIGH-RISK PROSTATE CANCER: EVIDENCE, RATIONALE, AND FUTURE DIRECTIONS
Lisa K. Morikawa et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
PHASE II STUDY OF VINORELBINE AND ESTRAMUSTINE IN COMBINATION WITH CONFORMATIONAL RADIOTHERAPY FOR PATIENTS WITH HIGH-RISK PROSTATE CANCER
Joan Carles et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Dosimetric risk estimates of radiation-induced malignancies after intensity modulated radiotherapy
Vijay M. Patil et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2010)
Intensity-Modulated Radiotherapy for Prostate Cancer Implementing Molecular Imaging with 18F-Choline PET-CT to Define a Simultaneous Integrated Boost
Michael Pinkawa et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2010)
Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95
Thomas Wiegel et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial
Ian M. Thompson et al.
JOURNAL OF UROLOGY (2009)
Dose-escalation using intensity-modulated radiotherapy for prostate cancer - Evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous integrated boost
Michael Pinkawa et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Bildgefuhrte Radiotherapie beim Prostatakarzinom. Anwendung der ultraschallbasierten Prostatalokalisation zur Analyse der inter- und intrafraktionellen Organbewegung
Michael Pinkawa et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2008)
Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01
Pascal Pommier et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: Updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions
Colleen A. Lawton et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Whole-pelvis, mini-pelvis, or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial
Mack Roach et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: A single institute experience of 415 patients
C Cozzarini et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Effect of fractionated regional external beam radiotherapy on peripheral blood cell count
B Zachariah et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Share Paper
